Alpha- and Beta-Blocker (Antihypertensive)
Pregnancy: C — used in pregnancy, monitor neonate
Labetalol
Brand names: Trandate
Adult dose
Dose: IV: 20mg bolus, repeat 40mg then 80mg every 10 min (max 300mg). Infusion: 20–160mg/hr. Oral: 100–200mg two to three times daily
Route: IV or Oral
Frequency: Per protocol
Target BP in pre-eclampsia: systolic 140–150 mmHg. Oral maintenance in pregnancy: 200mg BD, titrate up.
Clinical pearls
- First-line IV antihypertensive in acute severe hypertension in pregnancy
- Combined alpha+beta blockade — lowers BP without compromising uteroplacental blood flow
- Can cause neonatal bradycardia and hypoglycaemia — monitor neonate for 24h after delivery
- Avoid in asthma — safe alternative is nifedipine or hydralazine
- Do NOT use atenolol or metoprolol in pregnancy — associated with fetal growth restriction
Contraindications
- Asthma
- Heart block (>1st degree)
- Cardiogenic shock
- Severe bradycardia
Side effects
- Bradycardia
- Postural hypotension
- Bronchospasm
- Neonatal bradycardia (fetal passage)
- Dizziness
Interactions
- Cimetidine — increases labetalol bioavailability
- General anaesthetics — enhanced hypotension
- Verapamil — severe bradycardia/heart block risk
Monitoring
- Blood pressure (continuous IV monitoring)
- Fetal heart rate (CTG)
- Neonatal HR and glucose (post-delivery)
- HR (avoid bradycardia <60 bpm)
Reference: RCOG Hypertension in Pregnancy Guideline; NICE NG133. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- C-Peptide to Glucose Ratio · Diabetes Classification
- International Staging System (ISS) for Multiple Myeloma · Multiple Myeloma
- Revised ISS (R-ISS) for Multiple Myeloma · Haematological Malignancy
- International Staging System for Multiple Myeloma (ISS) · Oncology
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21